D-0070-2024 Class III Terminated

Recalled by Denver Solutions, LLC DBA Leiters Health — Englewood, CO

FDA drug recall D-0070-2024 was initiated by Denver Solutions, LLC DBA Leiters Health on Oct 4, 2023 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified The recall status is terminated (terminated Aug 15, 2024). Affected quantity: 6,276 IV bags.

Recall details

Product Type
Drugs
Report Date
Nov 1, 2023
Initiation Date
Oct 4, 2023
Termination Date
Aug 15, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6,276 IV bags

Product description

Oxytocin synthetic, 30 Units added to 0.9% Sodium Chloride 500mL IV Bag (0.06 Units per mL), Rx only, Leiter Compounding Health, 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-157-70

Reason for recall

Labeling: Not Elsewhere Classified

Distribution pattern

USA Nationwide

Code information

Lot#: 2330956, Exp. 10/23/2023; 2330964, Exp. 10/24/2023; 2331014, Exp. 11/6/2023; 2331033, Exp. 11/8/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0070-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0070-2024. Report a data issue: hello@regdatalab.com.